NCT01220167View on ClinicalTrials.gov

Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Healthy Participants
Interventions
DRUG

Ondansetron 8 mg ODFS without water

Single dose of Ondansetron 8 mg (ODFS) administered without water

DRUG

Ondansetron 8 mg ODFS with water

Single dose of Ondansetron 8 mg (ODSF) was orally administered, allowed to dissolve, swallowed with saliva, followed with water

DRUG

Zofran ODT (ondansetron 8 mg) without water

Single dose of Zofran ODT (containing ondansetron 8 mg) administered without water

Sponsors
All Listed Sponsors
lead

Aquestive Therapeutics

INDUSTRY

NCT01220167 - Three-way Crossover Study Comparing Ondansetron ODFS Administered With and Without Water to Zofran ODT Without Water | Biotech Hunter | Biotech Hunter